189
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Enumeration of viable CD34+ cells by flow cytometry in blood, bone marrow and cord blood: results of a study of the novel BD™ stem cell enumeration kit

, , , , &
Pages 449-458 | Received 02 Jul 2010, Accepted 01 Oct 2010, Published online: 15 Nov 2010

References

  • Armitage S, Hargreaves R, Samson D, Brennan M, Kanfer E, Navarrete C. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant. 1997;20:587–91.
  • Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M, . Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood. 1994;83: 3787–94.
  • Zaucha JM, Gooley T, Bensinger WI, Heimfeld S, Chauncey TR, Zaucha R, . CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood. 2001;98:3221–7.
  • Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry. 1998; 34:61–70.
  • Nakamura R, Auayporn N, Smith DD, Palmer J, Sun JY, Schriber J, . Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates. Biol Blood Marrow Transplant. 2008;14:449–57.
  • Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, . Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. Blood. 2009;114:2606–16.
  • Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, . An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood. 1995;86:3961–9.
  • Refaai MA, Cusick RM, Paranjape G, Sutor LJ. Low CD34 collection from a healthy blood progenitor cell donor: a case report. J Clin Apher. 2009;24:262–4.
  • Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5: 213–26.
  • Sutherland DR, Nayyar R, Acton E, Giftakis A, Dean S, Mosiman VL. Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometers. Cytotherapy. 2009;11: 595–605.
  • Gratama JW, Orfao A, Barnett D, Brando B, Huber A, Janossy G, . Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry. 1998;34: 128–42.
  • European Directorate of the Quality of Medicines and Healthcare. European Pharmacopoeia 6th. 2010.
  • Menendez P, Redondo O, Rodriguez A, Lopez-Berges MC, Ercilla G, Lopez A, . Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells. Cytometry. 1998;34: 264–71.
  • Keeney M, Chin-Yee I, Nayar R, Sutherland DR. Effect of fixatives on CD34+ cell enumeration. J Hematother Stem Cell Res. 1999;8:327–9.
  • Barnett D, Janossy G, Lubenko A, Matutes E, Newland A, Reilly JT. Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Prepared by the CD34+ Haematopoietic Stem Cell Working Party. General Haematology Task Force of the British Committee for Standards in Haematology. Clin Lab Haematol. 1999;21:301–8.
  • Chang A, Raik E, Marsden K, Ma DD. Australasian CD34+ quality assurance program and rationale for the clinical utility of the single-platform method for CD34+ cell enumeration. Cytotherapy. 2004;6:50–61.
  • Gratama JW, Orfao A, Barnett D, Brando B, Huber A, Janossy G, . Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry. 1998;34: 128–42.
  • Keeney M, Gratama JW, Sutherland DR. Critical role of flow cytometry in evaluating peripheral blood hematopoietic stem cell grafts. Cytometry A. 2004;58:72–5.
  • Humpe A, Beck C, Schoch R, Kneba M, Horst HA. Establishment and optimization of a flow cytometric method for evaluation of viability of CD34+ cells after cryopreservation and comparison with trypan blue exclusion staining. Transfusion. 2005;45:1208–13.
  • Chang A, Ma DD. The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. Australasian BMT Scientists Study Group. J Hematother. 1996;5:605–16.
  • Keeney M, Gratama JW, Chin-Yee IH, Sutherland DR. Isotype controls in the analysis of lymphocytes and CD34+ stem and progenitor cells by flow cytometry: time to let go! Cytometry. 1998;34:280–3.
  • Civin CI, Banquerigo ML, Strauss LC, Loken MR. Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp Hematol. 1987;15:10–7.
  • Krause DS, Ito T, Fackler MJ, Smith OM, Collector MI, Sharkis SJ, . Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood. 1994;84: 691–701.
  • Loken MR, Herzenber LA. Analysis of cell populations with a fluorescence-activated cell sorter. Ann NY Acad Sci. 1975;254: 163–71.
  • Brocklebank AM, Sparrow RL. Enumeration of CD34+ cells in cord blood: a variation on a single-platform flow cytometric method based on the ISHAGE gating strategy. Cytometry. 2001;46:254–61.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.